Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec 10;9(1):129-136.
doi: 10.1002/2211-5463.12558. eCollection 2019 Jan.

Presence of O-glycosidically linked oligosaccharides in the cell wall mannan of Candida krusei purified with Benanomicin A

Takuya Kuraoka  1 , Akito Ishiyama  2 , Hiroko Oyamada  1 , Yukiko Ogawa  1 , Hidemitsu Kobayashi  1
Affiliations

Presence of O-glycosidically linked oligosaccharides in the cell wall mannan of Candida krusei purified with Benanomicin A

Takuya Kuraoka et al. FEBS Open Bio. .

Abstract

Cell wall mannan of the pathogenic yeast Candida krusei was prepared using the antibiotic Benanomicin A, which has a lectin-like function. The chemical structure of this molecule was found to be similar to that of mannan prepared from the same yeast by the conventional method using Fehling reagent. Only a few degradation products were detected when the mannan prepared using Fehling reagent was subjected to alkali treatment (β-elimination), but multiple α-1,2-linked oligosaccharides were detected when the mannan purified with Benanomicin A was treated with alkali. These results indicate that most of the O-linked sugar chains in mannan were lost under conventional conditions when exposed to the strongly alkaline Fehling reagent. In contrast, the O-glycosidic bond in mannan was not cleaved and the O-linked sugar chains were maintained and almost intact following treatment with the mild novel preparation method using Benanomicin A. Therefore, we argue that the new mannan preparation method using Benanomicin A is superior to conventional methods. In addition, our study suggests that some yeast mannans, whose overall structure has already been reported, may contain more O-linked sugar chains than previously recognized.

Keywords: Benanomicin A; Candida krusei; O‐linked sugar; antibiotic; cell wall mannan; β‐elimination.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structure of Benanomicin A.
Figure 2
Figure 2
Procedure of Benanomicin method (A) and Fehling method (B).
Figure 3
Figure 3
1H‐NMR spectra (anomeric region) of Candida krusei mannan, Frs. K‐B (A) and K‐F (B).
Figure 4
Figure 4
Elution profiles of oligosaccharides obtained from Frs. K‐B (A) and K‐F (B) by the alkali treatment (β‐elimination). M4, M3, M2, and M indicate the eluted positions of standard mannooligosaccharides, tetraose, triose, biose, and mannose, respectively.
Figure 5
Figure 5
1H‐NMR spectra of oligosaccharides obtained from Frs. K‐B (A) and K‐F (B) by the alkali treatment (β‐elimination). M4, M3, and M2 indicate tetraose, triose, and biose, respectively.
Figure 6
Figure 6
Structure of O‐linked sugar chains in the cell wall mannan of Candida krusei. Ser, Thr, Asn and M indicate serine, threonine, asparagine and mannose, respectively. *The chemical structure of N‐linked sugar chains in this mannan is not clear yet.
See this image and copyright information in PMC

References

    1. Hegazi M, Abdelkader A, Zaki M and EI‐Deek B (2014) Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt. J Infect Dev Ctries 8, 624–634. - PubMed
    1. Gokcebay DG, Yarali N, Isik P, Bayram C, Ozkaya‐Parlakay A, Kara A and Tunc B (2016) Candida associated bloodstream infections in pediatric hematology patients: a single center experience. Mediterr J Hematol Infect Dis 8, 1–6. - PMC - PubMed
    1. Kakeya H, Yamada K, Kaneko Y, Yanagihara K, Tateda K, Maesaki S, Takesue Y, Tomono K, Kadota JI, Kaku M et al (2018) National trends in the distribution of Candida species causing Candidemia in Japan from 2003 to 2014. Med Mycol J 59, E19–E22. - PubMed
    1. Johnson LB and Kauffman CA (2003) Voriconazole: a new triazole antifungal agent. Clin Infect Dis 36, 630–637. - PubMed
    1. Pfaller MA, Moet GJ, Messer SA, Jones RN and Castanheira M (2011) Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J Clin Microbiol 49, 396–399. - PMC - PubMed

LinkOut - more resources